SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination - Top-Institutions - MDSpire

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

  • By

  • José Luis Piñana

  • Rodrigo Martino

  • Lourdes Vazquez

  • Lucia López-Corral

  • Ariadna Pérez

  • Pedro Chorão

  • Alejandro Avendaño-Pita

  • María-Jesús Pascual

  • Andrés Sánchez-Salinas

  • Gabriela Sanz-Linares

  • María T. Olave

  • Ignacio Arroyo

  • Mar Tormo

  • Lucia Villalon

  • Venancio Conesa-Garcia

  • Beatriz Gago

  • María-José Terol

  • Marta Villalba

  • Valentín Garcia-Gutierrez

  • Almudena Cabero

  • José Ángel Hernández-Rivas

  • Elena Ferrer

  • Irene García-Cadenas

  • Anabel Teruel

  • David Navarro

  • Ángel Cedillo

  • Anna Sureda

  • Carlos Solano

  • February 28, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Immunology
    • Infectious Diseases

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Cell Therapy
    • Infectious Diseases

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #4

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Barcelona, Catalonia

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Infectious Diseases
    • Clinical Research

  • #5

    National Institutes of Health (NIH) - National Cancer Institute (NCI)
    National Institutes of Health (NIH) - National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Immunology
    • Hematology
    • Infectious Diseases

Original Source(s)

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

  • by José Luis Piñana, Rodrigo Martino, Lourdes Vazquez, Lucia López-Corral, Ariadna Pérez, Pedro Chorão, Alejandro Avendaño-Pita, María-Jesús Pascual, Andrés Sánchez-Salinas, Gabriela Sanz-Linares, María T. Olave, Ignacio Arroyo, Mar Tormo, Lucia Villalon, Venancio Conesa-Garcia, Beatriz Gago, María-José Terol, Marta Villalba, Valentín Garcia-Gutierrez, Almudena Cabero, José Ángel Hernández-Rivas, Elena Ferrer, Irene García-Cadenas, Anabel Teruel, David Navarro, Ángel Cedillo, Anna Sureda, Carlos Solano

  • February 28, 2023

Related Content

The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper

Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan

MIS-C: Diagnosis, Management, and Outcomes